Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors
Abstract Bacterial cancer therapy was developed using probiotic Escherichia coli Nissle 1917 (EcN) for medical intervention of colorectal cancer. EcN was armed with HlyE, a small cytotoxic protein, under the control of the araBAD promoter (PBAD). The intrinsic limitation of PBAD for the gene express...
Guardado en:
Autores principales: | Chung-Jen Chiang, Po-Han Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ee22a175ea4c4ede806630b19979fd3b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy
por: Chung-Jen Chiang, et al.
Publicado: (2021) -
Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
por: In Young Hwang, et al.
Publicado: (2017) -
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
por: Sya N Ukena, et al.
Publicado: (2007) -
Anabaenolysins, novel cytolytic lipopeptides from benthic Anabaena cyanobacteria.
por: Jouni Jokela, et al.
Publicado: (2012) -
Metabolic engineering of Escherichia coli for de novo biosynthesis of vitamin B12
por: Huan Fang, et al.
Publicado: (2018)